Literature DB >> 29020096

Correction: Aclacinomycin A Sensitizes K562 Chronic Myeloid Leukemia Cells to Imatinib through p38MAPK-Mediated Erythroid Differentiation.

Yueh-Lun Lee, Chih-Wei Chen, Fu-Hwa Liu, Yu-Wen Huang, Huei-Mei Huang.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0061939.].

Entities:  

Year:  2017        PMID： 29020096      PMCID： PMC5636156          DOI： 10.1371/journal.pone.0186528

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


The affiliation for the first author is incorrect. Yueh-Lun Lee is affiliated with: Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
  1 in total

1.  Aclacinomycin A sensitizes K562 chronic myeloid leukemia cells to imatinib through p38MAPK-mediated erythroid differentiation.

Authors:  Yueh-Lun Lee; Chih-Wei Chen; Fu-Hwa Liu; Yu-Wen Huang; Huei-Mei Huang
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.